Salarius Pharmaceuticals (SLRX) Short Interest Ratio & Short Volume $0.69 -0.02 (-2.54%) As of 10:14 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Salarius Pharmaceuticals Short Interest DataSalarius Pharmaceuticals (SLRX) has a short interest of 112,900 shares, representing 5.43% of the float (the number of shares available for trading by the public). This marks a -18.31% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 1.27 million shares to cover all short positions.Current Short Interest112,900 sharesPrevious Short Interest138,200 sharesChange Vs. Previous Month-18.31%Dollar Volume Sold Short$81,288.00Short Interest Ratio0.4 Days to CoverLast Record DateApril 15, 2025Outstanding Shares2,127,000 sharesFloat Size2,080,000 sharesShort Percent of Float5.43%Today's Trading Volume6,648 sharesAverage Trading Volume1,271,334 sharesToday's Volume Vs. Average1% Short Selling Salarius Pharmaceuticals? Sign up to receive the latest short interest report for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLRX Short Interest Over TimeSLRX Days to Cover Over TimeSLRX Percentage of Float Shorted Over Time Salarius Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025112,900 shares $81,288.00 -18.3%5.4%0.4 $0.72 3/31/2025138,200 shares $104,202.80 +242.1%8.1%0.1 $0.75 3/15/202540,400 shares $39,188.00 -52.9%2.4%0 $0.97 2/28/202585,700 shares $92,556.00 +724.0%5.5%0 $1.08 2/15/202510,400 shares $16,848.00 -46.1%0.7%0 $1.62 1/31/202519,300 shares $43,232.00 -93.8%1.3%0 $2.24 1/15/2025311,700 shares $785,484.00 +902.3%20.2%0.2 $2.52 12/31/202431,100 shares $57,224.00 +18.3%2.2%0.1 $1.84 12/15/202426,300 shares $38,658.37 -27.8%1.9%0.1 $1.47 11/30/202436,400 shares $52,052.00 -33.8%2.6%0.1 $1.43 Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/202455,000 shares $73,700.00 -15.4%3.9%0.2 $1.34 10/31/202465,000 shares $104,650.00 +4,233.3%4.6%0.2 $1.61 10/15/20241,500 shares $2,280.00 -90.0%0.1%0 $1.52 9/30/202415,000 shares $21,600.00 +59.6%1.1%0 $1.44 9/15/20249,400 shares $14,664.00 -38.6%0.7%0 $1.56 8/31/202415,300 shares $25,398.00 -64.0%1.1%0 $1.66 8/15/202442,500 shares $85,425.00 -50.8%3.2%0 $2.01 7/31/202486,300 shares $220,928.00 +44.1%15.4%0 $2.56 7/15/202459,900 shares $106,622.00 +215.3%10.7%0 $1.78 6/30/202419,000 shares $45,220.00 +375.0%27.1%0.9 $2.38 6/15/20244,000 shares $13,526.40 -85.4%5.7%0.2 $3.38 5/31/202427,300 shares $12,645.36 -18.5%0.6%0.2 $0.46 5/15/202433,500 shares $15,343.00 -54.5%0.8%0.3 $0.46 4/30/202473,600 shares $36,726.40 -36.3%1.7%0.6 $0.50 4/15/2024115,600 shares $57,800.00 -57.0%2.6%1 $0.50 3/31/2024268,900 shares $142,140.54 +1,767.4%6.7%2.4 $0.53 3/15/202414,400 shares $9,360.00 -20.0%0.4%0.1 $0.65 2/29/202418,000 shares $12,060.00 +227.3%0.5%0.6 $0.67 2/15/20245,500 shares $3,245.00 -33.7%0.2%0.2 $0.59 1/31/20248,300 shares $4,556.70 +36.1%0.2%0.2 $0.55 1/15/20246,100 shares $3,721.00 -37.1%0.2%0.2 $0.61 12/31/20239,700 shares $6,305.00 +38.6%0.3%0.3 $0.65 12/15/20237,000 shares $4,515.00 -71.9%0.2%0.1 $0.65 11/30/202324,900 shares $17,679.00 -56.0%0.7%0.4 $0.71 11/15/202356,600 shares $40,752.00 -22.7%1.6%1.1 $0.72 10/31/202373,200 shares $61,334.28 +136.9%2.3%1.2 $0.84 10/15/202330,900 shares $21,321.00 +62.6%0.9%0.5 $0.69 9/30/202319,000 shares $12,500.08 -6.4%0.6%0.3 $0.66 9/15/202320,300 shares $17,395.07 -26.5%0.6%0.4 $0.86 8/31/202327,600 shares $24,285.24 +162.9%0.8%0.5 $0.88How to invest in Elon Musk’s Optimus before its launch (Ad)Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.Get all the information here. 8/15/202310,500 shares $7,490.70 +54.4%0.3%0.2 $0.71 7/31/20236,800 shares $6,249.20 -60.9%0.2%0.1 $0.92 7/15/202317,400 shares $19,314.00 -44.8%0.6%0.2 $1.11 6/30/202331,500 shares $46,935.00 -41.2%1.0%0.3 $1.49 6/15/202353,600 shares $85,224.00 +9.6%1.7%0.5 $1.59 5/31/202348,900 shares $68,949.00 -48.4%2.1%0.5 $1.41 5/15/202394,700 shares $136,368.00 -16.1%4.2%1 $1.44 4/30/2023112,800 shares $200,784.00 -11.9%5.4%1.3 $1.78 4/15/2023128,000 shares $220,160.00 +6.1%6.1%2.5 $1.72 3/31/2023120,700 shares $230,537.00 -4.2%5.8%0.8 $1.91 3/15/2023126,000 shares $255,780.00 -4.0%6.6%0.7 $2.03 2/28/2023131,300 shares $279,669.00 +16.7%6.8%0.7 $2.13 2/15/2023112,500 shares $252,000.00 +11.3%5.9%0.6 $2.24 1/31/2023101,100 shares $260,838.00 +37.7%5.2%0.6 $2.58 1/15/202373,400 shares $194,510.00 +272.6%3.8%0.4 $2.65 12/30/202219,700 shares $30,141.00 -46.6%1.0%0.3 $1.53 12/15/202236,900 shares $55,719.00 +93.2%1.9%0.8 $1.51 11/30/202219,100 shares $36,863.00 -12.0%1.0%0.4 $1.93 11/15/202221,700 shares $46,655.00 +100.9%1.1%0.5 $2.15 10/31/202210,800 shares $21,924.00 -31.2%0.5%0.3 $2.03 10/15/202215,700 shares $71,042.50 -95.8%0.8%0.4 $4.53 9/30/2022371,000 shares $72,345.00 -8.4%N/A0.9 $0.20 9/15/2022405,000 shares $95,904.00 +9.6%N/A0.8 $0.24 8/31/2022369,500 shares $74,269.50 -16.3%N/A0.7 $0.20 8/15/2022441,600 shares $99,360.00 +257.3%N/A0.7 $0.23 7/31/2022123,600 shares $23,508.72 +7.3%N/A0.1 $0.19 7/15/2022115,200 shares $21,876.48 -33.8%N/A0.1 $0.19 6/30/2022174,100 shares $36,561.00 -54.6%N/A0.1 $0.21 6/15/2022383,300 shares $77,733.24 -9.8%N/A0.3 $0.20 5/31/2022425,000 shares $76,627.50 -3.8%N/A0.4 $0.18 5/15/2022441,800 shares $83,014.22 -26.6%N/A0.4 $0.19 4/30/2022602,200 shares $121,644.40 +31.4%N/A1.1 $0.20 4/15/2022458,300 shares $163,658.93 -14.7%N/A1.1 $0.36 3/31/2022537,100 shares $213,819.51 +11.7%N/A1.3 $0.40 3/15/2022480,900 shares $165,429.60 -23.8%N/A1 $0.34 2/28/2022630,900 shares $252,423.09 +0.4%N/A1.8 $0.40 2/15/2022628,200 shares $285,831.00 -3.7%N/A1.7 $0.46 1/31/2022652,400 shares $293,580.00 -2.0%4.5%1.5 $0.45 1/15/2022665,600 shares $312,832.00 +4.2%4.6%1.4 $0.47 12/31/2021638,500 shares $316,440.60 -7.3%4.4%1.3 $0.50 12/15/2021688,600 shares $365,853.18 -35.0%4.7%1.4 $0.53 11/30/20211,060,000 shares $689,000.00 +1.0%7.3%1.5 $0.65 11/15/20211,050,000 shares $796,950.00 +7.5%7.2%1.1 $0.76 10/29/2021976,600 shares $808,331.82 -0.2%6.7%0.8 $0.83 10/15/2021978,900 shares $886,002.39 -24.1%6.7%0.8 $0.91 9/30/20211,290,000 shares $1.32 million -4.4%8.9%1 $1.02 9/15/20211,350,000 shares $1.39 million -2.9%9.3%1 $1.03 8/31/20211,390,000 shares $1.45 million +9.5%9.6%1 $1.04 8/13/20211,270,000 shares $1.17 million -8.0%8.8%0.7 $0.92 7/30/20211,380,000 shares $1.12 million -9.2%9.5%0.8 $0.81How to invest in Elon Musk’s Optimus before its launch (Ad)Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.Get all the information here. 7/15/20211,520,000 shares $1.38 million -19.2%10.5%0.9 $0.91 6/30/20211,880,000 shares $1.99 million +0.5%13.0%1.1 $1.06 6/15/20211,870,000 shares $2.24 million +14.7%12.9%1.1 $1.20 5/28/20211,630,000 shares $2.09 million -2.4%11.3%1 $1.28 5/14/20211,670,000 shares $2.04 million +29.5%N/A1.3 $1.22 4/30/20211,290,000 shares $1.72 million -5.8%N/A0.6 $1.33 4/15/20211,370,000 shares $1.78 million -12.7%N/A0.6 $1.30 3/31/20211,570,000 shares $2.25 million +41.4%N/A0.6 $1.43 3/15/20211,110,000 shares $1.81 million -41.6%N/A0.4 $1.63 2/26/20211,900,000 shares $3.67 million +15.2%N/A0.7 $1.93 2/12/20211,650,000 shares $4.36 million +202.6%N/A0.6 $2.64 1/29/2021545,200 shares $594,268.00 -11.3%N/A0.3 $1.09 1/15/2021614,300 shares $712,588.00 +7.3%N/A0.6 $1.16 12/31/2020572,800 shares $510,937.60 +22.8%N/A0.7 $0.89 12/15/2020466,600 shares $407,295.14 -2.1%N/A0.8 $0.87 11/30/2020476,400 shares $325,857.60 -18.6%N/A1.1 $0.68 11/15/2020585,000 shares $427,050.00 +3.0%N/A3.9 $0.73 10/30/2020568,000 shares $382,434.40 -11.4%N/A3.6 $0.67 10/15/2020640,800 shares $583,128.00 -5.2%N/A2.8 $0.91 9/30/2020675,900 shares $570,392.01 +22.7%N/A2.9 $0.84 9/15/2020551,100 shares $506,736.45 -4.2%N/A2.2 $0.92 8/31/2020575,000 shares $540,500.00 +1.4%N/A1.6 $0.94 8/14/2020567,000 shares $569,835.00 -40.8%N/A1 $1.01 7/31/2020958,000 shares $1.10 million +3.7%N/A1.4 $1.15 7/15/2020924,200 shares $1.22 million -6.1%N/A1.3 $1.32 6/30/2020984,200 shares $1.30 million +0.6%N/A1.4 $1.32 6/15/2020978,400 shares $1.50 million +48.5%N/A1.4 $1.53 5/29/2020659,000 shares $691,950.00 +120.0%N/A1.1 $1.05 5/15/2020299,600 shares $254,689.96 +14.5%N/A0.7 $0.85 SLRX Short Interest - Frequently Asked Questions What is Salarius Pharmaceuticals' current short interest? Short interest is the volume of Salarius Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 112,900 shares of SLRX short. 5.43% of Salarius Pharmaceuticals' shares are currently sold short. Learn More on Salarius Pharmaceuticals' current short interest. Which institutional investors are shorting Salarius Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Salarius Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Salarius Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.43% of Salarius Pharmaceuticals' floating shares are currently sold short. Is Salarius Pharmaceuticals' short interest increasing or decreasing? Salarius Pharmaceuticals saw a decline in short interest in April. As of April 15th, there was short interest totaling 112,900 shares, a decline of 18.3% from the previous total of 138,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Salarius Pharmaceuticals' float size? Salarius Pharmaceuticals currently has issued a total of 2,127,000 shares. Some of Salarius Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Salarius Pharmaceuticals currently has a public float of 2,080,000 shares. How does Salarius Pharmaceuticals' short interest compare to its competitors? 5.43% of Salarius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Salarius Pharmaceuticals: 60 Degrees Pharmaceuticals, Inc. (30.91%), 180 Life Sciences Corp. (13.02%), Alzamend Neuro, Inc. (3.54%), NuCana plc (0.21%), Clearmind Medicine Inc. (3.95%), Aptorum Group Limited (1.15%), Adial Pharmaceuticals, Inc. (3.36%), Dermata Therapeutics, Inc. (2.73%), Mustang Bio, Inc. (3.10%), Sonnet BioTherapeutics Holdings, Inc. (5.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Salarius Pharmaceuticals stock? Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. SLRX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Salarius Pharmaceuticals? A short squeeze for Salarius Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRX, which in turn drives the price of the stock up even further. How often is Salarius Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRX, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies SXTP Short Interest ATNF Short Interest ALZN Short Interest NCNA Short Interest CMND Short Interest APM Short Interest ADIL Short Interest DRMA Short Interest MBIO Short Interest SONN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLRX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLRX Stock Free SLRX Stock Alerts